NASDAQ:CDAK

Codiak BioSciences, Inc Earning Date

USA |NASDAQ |USD

CDAK Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 17, 2021 Sep 2021 $-1.07 $-0.99 $-12.83
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 17, 2021 Sep 2021 $1.26M $890.00K $954.00K

Codiak Biosciences, Inc's next earnings date is Wednesday, Nov 17, 2021 for the fiscal quarter ending Sep 2021.

CDAK Earnings Date & History Chart

CDAK Earnings & Revenue Forecast

CDAK Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 3 $-1.11 $-1.41 $-0.90
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 3 $-3.71 $-4.27 $-3.31
Dec 2022 3 $-3.96 $-5.25 $-3.30

CDAK Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-1.11 $-1.11 $-1.15
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-3.71 $-3.71 $-3.83
Dec 2022 0 / 0 $-3.96 $-3.96 $-4.21

CDAK Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 3 $1.25M $0.00 $2.87M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 3 $16.59M $14.08M $19.82M
Dec 2022 3 $4.82M $0.00 $9.73M

CDAK Earnings Date & Revenue History

CDAK Earnings History

|
Show More
Show More

CDAK Revenue History

|
Show More
Show More

Codiak Biosciences, Inc Next Earnings Date & Report

CDAK Next Earnings Date & Report Preview: Sep 2021 (FQ)

CDAK's next earnings date is Wednesday, Nov 17, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 3 analysts, the average EPS estimation for Codiak Biosciences, Inc's next quarterly earnings is $-1.07, with a low EPS estimation of $-1.31, and a high estimation of $-0.90.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-1.07, the last 2 month trend is $-1.07, and the 3 month trend is $-1.10.

Based on 3 analysts, the average revenue estimation is $1.26M, with a low revenue estimation of $0.00, and a high estimation of $2.87M.

Codiak Biosciences, Inc Previous Earnings Dates & Reports

CDAK Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Codiak Biosciences, Inc's previous earnings date was Aug 5, 2021 for its fiscal quarter ended Jun 30, 2021.

CDAK's earnings per share (EPS) was $-0.99, beating the consensus analysts forecast of $-1.05 by 5.42%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 94.12%.

Revenues were $890.00K, worse than the forecast of $1.35M by -34.07%, down by -93.25% from the previous quarter , and up by 375.94% from the same period last year.

The company reported a net income of $-21.81M.

Free cash flow for the quarter was $-18.52M , compared to $-21.16M last quarter and $519.00K a year before.

CDAK Previous Earnings Date & Report Recap: Dec 2020 (FY)

Codiak Biosciences, Inc's previous annual earnings date was Mar 17, 2021 for its fiscal year ended Dec 31, 2020.

CDAK's earnings per share (EPS) was $-13.97.

Revenues were $2.92M, better than the forecast of $1.81M by 61.05%, and up by 651.29% from previous year's revenue.

The company reported a net income of $-91.67M.

Codiak Biosciences, Inc reported a free cash flow of $-84.41M for its fiscal year, compared to $-12.18M a year ago.

The company ended the fiscal year with $26.44M in total debt, a decrease of -68.00% compared to the previous year.